The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study

被引：0

作者：

Akito Nozaki

Masanori Atsukawa

Chisa Kondo

Hidenori Toyoda

Makoto Chuma

Makoto Nakamuta

Haruki Uojima

Koichi Takaguchi

Hiroki Ikeda

Tsunamasa Watanabe

Shintaro Ogawa

Norio Itokawa

Taeang Arai

Atsushi Hiraoka

Toru Asano

Shinichi Fujioka

Tadashi Ikegami

Toshihide Shima

Chikara Ogawa

Takehiro Akahane

Noritomo Shimada

Shinya Fukunishi

Hiroshi Abe

Akihito Tsubota

Takuya Genda

Hironao Okubo

Shigeru Mikami

Asahiro Morishita

Akio Moriya

Joji Tani

Yoshihiko Tachi

Naoki Hotta

Toru Ishikawa

Takeshi Okanoue

Yasuhito Tanaka

Takashi Kumada

Katsuhiko Iwakiri

Shin Maeda

机构：

[1] Yokohama City University Medical Center,Gastroenterological Center

[2] Nippon Medical School,Department of Internal Medicine, Division of Gastroenterology and Hepatology

[3] Ogaki Municipal Hospital,Department of Gastroenterology

[4] National Hospital Organization Kyushu Medical Center,Department of Gastroenterology, Internal Medicine

[5] Kitasato University School of Medicine,Department of Hepatology

[6] Kagawa Prefectural Central Hospital,Department of Internal Medicine

[7] St. Marianna University School of Medicine,Department of Virology and Liver Unit

[8] Nagoya City University,Division of Gastroenterology, Department of Internal Medicine

[9] Graduate School of Medical Sciences,Division of Gastroenterology, Department of Internal Medicine

[10] Nippon Medical School Chiba Hokusoh Hospital,Gastroenterology Center

[11] Nippon Medical School Musashikosugi Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[12] Ehime Prefectural Central Hospital,Department of Gastroenterology

[13] Tokyo Metropolitan Bokutoh Hospital,Department of Gastroenterology and Hepatology

[14] Okayama Saiseikai General Hospital,Department of Gastroenterology and Hepatology

[15] Tokyo Medical University Ibaraki Medical Center,Department of Gastroenterology

[16] Saiseikai Suita Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[17] Takamatsu Red Cross Hospital,Second Department of Internal Medicine

[18] Japanese Red Cross Ishinomaki Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[19] Otakanomori Hospital,Core Research Facilities for Basic Science

[20] Osaka Medical College,Department of Gastroenterology

[21] Shinmatsudo Central General Hospital,Department of Gastroenterology

[22] The Jikei University School of Medicine,Division of Gastroenterology, Department of Internal Medicine

[23] Juntendo Shizuoka University Hospital,Department of Gastroenterology

[24] Juntendo Nerima University Hospital,Department of Gastroenterology

[25] Kikkoman General Hospital,Department of Internal Medicine

[26] Kagawa University Graduate School of Medicine,Division of Hepatology, Department of Internal Medicine

[27] Mitoyo General Hospital,Department of Hepatology

[28] Yashima General Hospital,Department of Gastroenterology

[29] Bantane Hospital,undefined

[30] Fujita Health University School of Medicine,undefined

[31] Masuko Memorial Hospital,undefined

[32] Saiseikai Niigata Daini Hospital,undefined

[33] Yokohama City University Graduate School of Medicine,undefined

来源：

Hepatology International | 2020年 / 14卷

关键词：

Glecaprevir; Pibrentasvir; Chronic hepatitis C; Refractory factors; Multicenter study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：225 / 238

页数：13

共 50 条

[41] Intention-to-treat assessment of glecaprevir plus pibrentasvir combination therapy for patients with chronic hepatitis C in the real world
Tamori, Akihiro
Inoue, Kazuaki
Kagawa, Tatehiro
Takaguchi, Koichi
Nouso, Kazuhiro
Iwasaki, Yoshiaki
Minami, Masahito
Hai, Hoang
Enomoto, Masaru
Kawada, Norifumi
HEPATOLOGY RESEARCH, 2019, 49 (12) : 1365 - 1373
[42] Real-world safety, effectiveness, and patient-reported outcomes in patients with chronic hepatitis C virus infection treated with glecaprevir/pibrentasvir: Data from the German Hepatitis C-Registry
Cornberg, Markus
Stoehr, Albrecht
Uwe, Naumann
Klinker, Hartwig
Thomas, Lutz
Schiffelholz, Willibold
Qurishi, Nazifa
Pangerl, Andreas
Lohmann, Kristina
Koenig, Bettina
Simon, Karl-Georg
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E45 - E45
[43] Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study
Cabalak, Mehmet
Bal, Tayibe
Ocak, Sabahattin
Bal, Isa Ahmet
Onlen, Yusuf
HEPATITIS MONTHLY, 2023, 23 (01)
[44] A real-world clinical application of the combination therapy with glecaprevir/pibrentasvir to special population in chronic hepatitis C patients
Sato, Ken
Yamazaki, Yuichi
Kobayashi, Takeshi
Tojima, Hiroaki
Horiguchi, Norio
Kakizaki, Satoru
Uraoka, Toshio
Ohnishi, Hiroshi
Okamoto, Hiroaki
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 444 - 444
[45] CLINICAL AND VIROLOGICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS C AND FAILURE TO A GLECAPREVIR AND PIBRENTASVIR (G/P) TREATMENT IN REAL WORLD
Garcia Garcia, Federico
Dietz, Julia
Di Maio, Velia Chiara
Vermehren, Johannes
De Salazar, Adolfo
Paolucci, Stefania
Mullhaupt, Beat
Coppola, Nicola
Cabezas, Joaquin
Stauber, Rudolf E.
Puoti, Massimo
Arenas Ruiz-Tapiador, Juan Ignacio
Aragri, Marianna
Jimenez, Miguel
Callegaro, Annapaola
Pascasio Acevedo, Juan Manuel
Macias Rodriguez, Manuel Alberto
Rosales Zabal, Jose Miguel
Micheli, Valeria
Gomez, Neus
Tellez, Francisco
Sarrazin, Christoph
Silberstein, Francesca Ceccherini
HEPATOLOGY, 2019, 70 : 998A - 999A
[46] Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic Hepatitis C aged 75 years or older: A multicenter study
Pugliese, N.
Calvaruso, V.
Masarone, M.
D'Ambrosio, R.
Battistella, S.
Licata, A.
Persico, M.
Anolli, M. P.
Distefano, M.
Petta, S.
Russo, F. P.
Di Marco, V.
Aghemo, A.
DIGESTIVE AND LIVER DISEASE, 2023, 55 : S26 - S26
[47] COMPARISON OF GLECAPREVIR/PIBRENTASVIR AND SOFOSBUVIR/LEDIPASVIR AS PANGENOTYPIC DAA IN PATIENTS WITH CHRONIC HEPATITIS C IN SOUTH KOREA: MULTICENTER STUDY
Kim, SukBae
Song, Han, II
Lee, Sae Hwan
Kim, Hong Soo, II
Lee, Tae Hee
Soo, Eun Hyuk
Kim, Seok Hyun
Lee, Byung Seok
Chae, Hee Bok
Song, Myeong Jun
Ko, Soon Young
HEPATOLOGY, 2022, 76 : S386 - S386
[48] Real-World Effectiveness of Glecaprevir/Pibrentasvir in 1,941 Patients with Hepatitis C Genotypes 1 through 4
Belperio, Pamela S.
Shahoumian, Troy
Loomis, Timothy
Mole, Larry
Backus, Lisa I.
HEPATOLOGY, 2018, 68 : 417A - 418A
[49] The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study
Atsukawa, Masanori
Tsubota, Akihito
Toyoda, Hidenori
Takaguchi, Koichi
Nakamuta, Makoto
Watanabe, Tsunamasa
Michitaka, Kojiro
Ikegami, Tadashi
Nozaki, Akito
Uojima, Haruki
Fukunishi, Shinya
Genda, Takuya
Abe, Hiroshi
Hotta, Naoki
Tsuji, Kunihiko
Ogawa, Chikara
Tachi, Yoshihiko
Shima, Toshihide
Shimada, Noritomo
Kondo, Chisa
Akahane, Takehiro
Aizawa, Yoshio
Tanaka, Yasuhito
Kumada, Takashi
Iwakiri, Katsuhiko
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (09) : 1230 - 1241
[50] Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease
Aglitti, A.
Caruso, R.
Calvanese, G.
Di Siervi, P.
Tripodi, M. F.
Masarone, M.
Persico, M.
DIGESTIVE AND LIVER DISEASE, 2019, 51 : E66 - E66

← 1 2 3 4 5 →